Cargando…
SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments
Multiple myeloma (MM) is a common hematological malignancy that has fostered several new therapeutic approaches to combat newly diagnosed or relapsed MM. While the field has advanced over the past 2 decades, the majority of patients will develop resistance to these treatments, causing the need for n...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529721/ https://www.ncbi.nlm.nih.gov/pubmed/37754488 http://dx.doi.org/10.3390/curroncol30090573 |